Nautilus Biotechnology, Inc. (NAUT)
2.035
0.00 (0.00%)
USD |
NASDAQ |
Dec 10, 16:00
2.035
0.00 (0.00%)
After-Hours: 20:00
Nautilus Biotechnology Shareholders Equity (Quarterly): 169.14M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Prelude Therapeutics, Inc. | 58.53M |
| Protalix Biotherapeutics, Inc. | 52.91M |
| Genprex, Inc. | 0.7678M |
| GoodRx Holdings, Inc. | 600.71M |
| Pelthos Therapeutics, Inc. | 58.25M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 200.92M |
| Total Liabilities (Quarterly) | 31.78M |
| Debt to Equity Ratio | 0.1597 |
| Current Ratio | 14.95 |
| Net Debt Paydown Yield | 1.05% |